Posterior reversible encephalopathy syndrome and heart failure tacrolimus-induced after liver transplantation: A case report

5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

BACKGROUND Patients undergoing liver transplantation can develop posterior reversible encephalopathy syndrome (PRES) and acute heart failure (HF) in the postoperative period. But PRES with HF caused by tacrolimus has rarely been described. CASE SUMMAR A 40-year-old female patient who had a normal preoperative cardiac and neural evaluation developed PRES with acute heart failure tacrolimus-induced after liver transplantation. The challenges associated with both diagnosis and management in the setting of a newly implanted graft are discussed. CONCLUSION Tacrolimus can induce neurotoxicity and then cardiac toxicity. Magnetic resonance imaging, echocardiography, and increased brain natriuretic peptide may be predictive of post-operative PRES with acute heart failure. Further investigations are necessary to verify this finding.

Cite

CITATION STYLE

APA

Liu, J. F., Shen, T., & Zhang, Y. T. (2020). Posterior reversible encephalopathy syndrome and heart failure tacrolimus-induced after liver transplantation: A case report. World Journal of Clinical Cases, 8(13), 2870–2875. https://doi.org/10.12998/wjcc.v8.i13.2870

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free